XML 63 R46.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS’ DEFICIENCY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 21, 2021
Dec. 31, 2020
May 22, 2020
Jan. 09, 2020
Sep. 30, 2021
Sep. 30, 2021
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Class of Stock [Line Items]                  
Common Stock, Shares Authorized             125,000,000 125,000,000  
Common Stock, Par or Stated Value Per Share             $ 0.001 $ 0.001  
Preferred Stock, Shares Authorized             10,000,000 10,000,000  
Preferred Stock, Par or Stated Value Per Share             $ 0.001 $ 0.001  
Number of warrant issued             60,000    
Common Stock, Shares, Issued             49,810,322 36,124,964  
Common Stock, Other Shares, Outstanding             1,466,718 2,889,978  
Preferred Stock, Shares Outstanding             1 1  
Beneficially qwnership shares             49,810,322 36,124,964  
Stock Issued During Period, Value, New Issues             $ 250,000 $ 5,758,572  
Number of common stock compensation for services               1,900,042  
Stock Issued During Period, Shares, Issued for Services             250,000    
Issuance of shares for services             $ 1,414,449 $ 2,598,863  
Stock and preference stock             100,000 200,000  
Proceeds from Issuance of Common Stock           $ 14,545,805 $ 250,000  
Shares outstanding             123,817    
Number of warrants issued             446,370 97,500  
Fair value of warrants $ 1,042,149                
Class of Warrant or Right, Outstanding             658,355 97,500  
Proceeds from warrant exercise             $ 872,292 $ 67,941  
Share-Based Payment Arrangement, Noncash Expense             913,613 $ 790,535  
Intrinsic value             $ 0    
2016 Equity Incentive Plan [Member]                  
Class of Stock [Line Items]                  
Number of common stock compensation for services, value                 $ 1,600,515
Expected life                 10 years
Share Price                 $ 0.974
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross             596,458 2,610,647  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term             5 years 9 months 8 years 8 months 12 days  
Share-Based Payment Arrangement, Noncash Expense             $ 913,613 $ 790,535  
Minimum [Member]                  
Class of Stock [Line Items]                  
Expected life             2 years 2 years 2 years
Exercise price             $ 2.40 $ 1.40 $ 1.40
Minimum [Member] | 2016 Equity Incentive Plan [Member]                  
Class of Stock [Line Items]                  
Expected life                 3 years
Rate of return                 0.46%
Maximum [Member]                  
Class of Stock [Line Items]                  
Expected life             10 years 10 years 3 years
Exercise price             $ 3.98 $ 2.00 $ 2.00
Maximum [Member] | 2016 Equity Incentive Plan [Member]                  
Class of Stock [Line Items]                  
Rate of return                 0.75%
Uplisting Public Stock Offering [Member]                  
Class of Stock [Line Items]                  
Number of warrant issued             5,382,331    
Shares conversion of convertible securities             69,252    
Proceeds from Issuance of Common Stock             $ 14,545,805    
Series A Notes [Member]                  
Class of Stock [Line Items]                  
Number of stock issued during the period convertible, shares             18,402 733,085  
Convertible Promissory Notes [Member]                  
Class of Stock [Line Items]                  
Number of stock issued during the period convertible, shares             4,696,083    
Repayments of Debt             $ 14,522,812 $ 1,011,286  
Convertible Notes Payable             10,309,000 739,000  
Debt Instrument, Convertible, Beneficial Conversion Feature             3,398,557 225,284  
Unpaid interest amount             815,255 47,002  
Stock Issued During Period, Value, New Issues             15,678,454 1,076,561  
Fair value of stock to be issued             $ 1,155,642 38,460  
Loss on conversion of convertible promissory notes               103,375  
Shares conversion of convertible securities             19,263    
Warrant [Member]                  
Class of Stock [Line Items]                  
Number of warrant issued             658,355    
Number of common stock compensation for services             212,594    
Stock Issued During Period, Shares, Issued for Services             451,688    
Cash receipt amount             $ 872,292 67,941  
Proceeds from warrant exercise             $ 103,950    
Cashless Warrant [Member]                  
Class of Stock [Line Items]                  
Number of warrant issued             446,370    
Shares To Be Issued [Member]                  
Class of Stock [Line Items]                  
Stock Issued During Period, Value, New Issues              
Shares conversion of convertible securities             (19,263)    
Stock Issued During Period, Shares, Issued for Services             (250,000) 89,652  
Issuance of shares for services             $ (242,500) $ 111,470  
Stock and preference stock             $ 250,000    
Shares outstanding             123,817 268,402 178,750
Exchange Agreement [Member] | 11% Secured Convertible Promissory Notes [Member]                  
Class of Stock [Line Items]                  
Conversion of Stock, Description             The outstanding 11% secured convertible promissory notes of the Company were adjusted, in accordance with the adjustment provisions thereof, as and from closing, so as to permit the holders to convert (and in some circumstances permit the Company to force the conversion of) the convertible promissory notes into shares of the common stock of Biotricity at a 25% discount to purchase price per share in Biotricity’s next offering    
Discount percentage for purchase price per shares             25.00%    
Exchange Agreement [Member] | Warrant [Member]                  
Class of Stock [Line Items]                  
Common stock exchange description             1.197 shares of the common stock of Biotricity for each Warrant, with an inverse adjustment to the exercise price of the Warrants to reflect the exchange ratio of approximately 1.197:1    
Exchange Agreement [Member] | Advisor Warrant [Member]                  
Class of Stock [Line Items]                  
Common stock exchange description             1.197 shares of the common stock of Biotricity for each Advisor Warrant, with an inverse adjustment to the exercise price of the Advisor Warrants to reflect the exchange ratio of approximately 1.197:1    
Exchange Agreement [Member] | Options [Member]                  
Class of Stock [Line Items]                  
Common stock exchange description             1.197 economically equivalent replacement options with an inverse adjustment to the exercise price of the replacement option to reflect the exchange ratio of approximately 1.197:1    
Exchange Agreement Axis [Member]                  
Class of Stock [Line Items]                  
Percentage of common stock issued and outstanding             9000.00%    
Shareholders [Member] | Exchange Agreement [Member]                  
Class of Stock [Line Items]                  
Number of warrant issued             51,277,040 39,014,942  
Common stock exchange description             1.197 shares of its common stock in exchange for each common share of the Company held by the Company shareholders who in general terms, are not residents of Canada (for the purposes of the Income Tax Act (Canada). Accordingly, the Company issued 13,376,947 shares    
Shareholders [Member] | Exchange Agreement Axis [Member]                  
Class of Stock [Line Items]                  
Number of warrant issued             13,376,947    
Chief Executive Officer [Member] | Exchange Agreement Axis [Member]                  
Class of Stock [Line Items]                  
Beneficially qwnership shares             6,500,000    
Exchangeco [Member] | Exchange Agreement [Member]                  
Class of Stock [Line Items]                  
Common stock exchange description             1.197 Exchangeable Shares in the capital of Exchangeco in exchange for each common share of the Company held. Accordingly, the Company issued 9,123,031 Exchangeable Shares    
Number of exchangeable shares issued             9,123,031    
Investors [Member]                  
Class of Stock [Line Items]                  
Number of warrant issued             1,423,260 898,084  
AdvisorAndConsultantTwoMember | Warrant [Member]                  
Class of Stock [Line Items]                  
Number of common stock compensation for services             25,000 449,583  
Number of common stock compensation for services, value               $ 275,801  
Fair value of warrants             $ 541,443    
AdvisorAndConsultantTwoMember | Warrant [Member] | Minimum [Member]                  
Class of Stock [Line Items]                  
Expected life   3 years              
AdvisorAndConsultantTwoMember | Warrant [Member] | Maximum [Member]                  
Class of Stock [Line Items]                  
Expected life   10 years              
Chief Financial Officer [Member] | Warrant [Member]                  
Class of Stock [Line Items]                  
Warrants issued   788,806           288,806  
Fair value of warrants               $ 464,971  
Brokers [Member] | Warrant [Member]                  
Class of Stock [Line Items]                  
Number of warrants issued               1,065,857  
Convertible Note Holders [Member] | Warrant [Member]                  
Class of Stock [Line Items]                  
Number of warrants issued               5,631,132  
Executive Officer [Member] | Warrant [Member]                  
Class of Stock [Line Items]                  
Number of common stock compensation for services             187,594    
Lenders [Member] | Warrant [Member]                  
Class of Stock [Line Items]                  
Number of warrants issued             57,536    
Warrants and Rights Outstanding             $ 198,713    
Expixy date             Dec. 21, 2028    
Exercise price             $ 6.26    
Rate of return             1.40%    
Volatility rate             121.71%    
Underwriter [Member] | Warrant [Member]                  
Class of Stock [Line Items]                  
Number of warrants issued             373,404    
Warrants and Rights Outstanding             $ 900,371    
Expixy date             Aug. 26, 2026    
Exercise price             $ 3.75    
Rate of return             0.77%    
Volatility rate             111.90%    
Employee [Member] | 2016 Equity Incentive Plan [Member]                  
Class of Stock [Line Items]                  
Expected life             10 years    
Board of Director [Member] | 2016 Equity Incentive Plan [Member]                  
Class of Stock [Line Items]                  
Expected life                 10 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate                 132.20%
Series A Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred Stock, Shares Authorized             20,000 20,000  
Preferred Stock, Par or Stated Value Per Share             $ 0.001 $ 0.001  
Number of warrant issued     100 6,000 100   288,756    
Preferred Stock, Shares Outstanding             7,200 8,045  
Dividends, Preferred Stock               $ 962,148  
Dividends, Cash               $ 602,969  
Stock and preference stock     $ 100,000 $ 6,000,000 $ 100,000   $ 100,000    
Issuance of preferred shares for private placement investors shares             100